Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Contineum Therapeutics, Inc.(CTNM) | 918,163 | 918,163 | 0 | 16,169 | 17,574 | 27.64% | +1,405 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 8,734 | 9,105 | 14.32% | +371 |
| Adverum Biotechnologies, Inc. | 506,821 | 506,821 | 0 | 3,477 | 3,558 | 5.60% | +81 |
| Gritstone Oncology, Inc. | 3,561,150 | 3,561,150 | 0 | 2,200 | 2,065 | 3.25% | -135 |
| Aligos Therapeutics, Inc. | 1,457,937 | 0 | -1,457,937 | 510 | 0 | — | -510 |
| Passage Bio, Inc.(PASG) | 4,026,417 | 0 | -4,026,417 | 3,198 | 0 | — | -3,198 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 498,558 | 0 | 26,927 | 23,422 | 36.84% | -3,505 |
| Skye Bioscience, Inc.(SKYE) | 2,007,704 | 2,007,704 | 0 | 16,082 | 7,850 | 12.35% | -8,232 |